Other studies have shown CD36 to be anti-angiogenic via thrombospondin-1 signaling, leading to apoptosis in normal EC, or by blocking the vascular endothelial growth factor receptor 2 pathway in tumor EC (79). This evidence concerns the gene CD36 and neoplasm.